Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thumbi Ndung'u

Showing results (1-10 of 350) with videos related to

Pageof 35
Sort By:
Retrovirology|October 17, 2023
The KT Jeang retrovirology prize 2023: Thumbi Ndung'uThumbi Ndung'u
Virulence|July 16, 2011
TRIM E3 ligases in HIV infection: can these intrinsic immunity factors be harnessed for novel vaccines or therapies?Thumbi Ndung'u
Med (New York, N.Y.)|May 19, 2022
Will Long-Acting Antiretroviral Therapy be a Game Changer Globally?Thumbi Ndung'u
Nature Microbiology|September 28, 2023
Fighting HIV where it matters mostThumbi Ndung'u
Scientific American|June 2, 2012
Resistance fighter. Interview by Brendan BorrellThumbi Ndung'u
Current Opinion in HIV and AIDS|March 24, 2026
Virological biomarkers of HIV remission in children: implications for pediatric cure strategiesKavidha Reddy, Thumbi Ndung'u
AIDS (London, England)|June 19, 2012
On HIV diversityThumbi Ndung'u, Robin A Weiss
The New England Journal of Medicine|June 18, 2010
Case records of the Massachusetts General Hospital. Case 18-2010. A 7-year-old boy with elevated HIV RNA levels despite antiretroviral medicationsTammy M Meyers, Thumbi Ndung'u
Virology Journal|January 25, 2015
HIV-1 vaccine immunogen design strategiesJaclyn K Mann, Thumbi Ndung'u
Current Opinion in Hematology|November 22, 2013
Neutrophil counts in persons of African originChristina F Thobakgale, Thumbi Ndung'u
Pageof 35

Showing results (1-10 of 350) with videos related to

Sort By:
Pageof 35
Retrovirology|October 17, 2023
The KT Jeang retrovirology prize 2023: Thumbi Ndung'uThumbi Ndung'u
Virulence|July 16, 2011
TRIM E3 ligases in HIV infection: can these intrinsic immunity factors be harnessed for novel vaccines or therapies?Thumbi Ndung'u
Med (New York, N.Y.)|May 19, 2022
Will Long-Acting Antiretroviral Therapy be a Game Changer Globally?Thumbi Ndung'u
Nature Microbiology|September 28, 2023
Fighting HIV where it matters mostThumbi Ndung'u
Scientific American|June 2, 2012
Resistance fighter. Interview by Brendan BorrellThumbi Ndung'u
Current Opinion in HIV and AIDS|March 24, 2026
Virological biomarkers of HIV remission in children: implications for pediatric cure strategiesKavidha Reddy, Thumbi Ndung'u
AIDS (London, England)|June 19, 2012
On HIV diversityThumbi Ndung'u, Robin A Weiss
The New England Journal of Medicine|June 18, 2010
Case records of the Massachusetts General Hospital. Case 18-2010. A 7-year-old boy with elevated HIV RNA levels despite antiretroviral medicationsTammy M Meyers, Thumbi Ndung'u
Virology Journal|January 25, 2015
HIV-1 vaccine immunogen design strategiesJaclyn K Mann, Thumbi Ndung'u
Current Opinion in Hematology|November 22, 2013
Neutrophil counts in persons of African originChristina F Thobakgale, Thumbi Ndung'u
Pageof 35